Macugen (Bausch & Lomb Incorporated)


Welcome to the PulseAid listing for the Macugen drug offered from Bausch & Lomb Incorporated. This Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bausch & Lomb Incorporated
NON-PROPRIETARY NAME: pegaptanib sodium
SUBSTANCE NAME: PEGAPTANIB SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient]
ROUTE: INTRAVITREAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-12-17
END MARKETING DATE: 0000-00-00


Macugen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMacugen from Bausch & Lomb Incorporated
LABELER NAME: Bausch & Lomb Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 3.47(mg/mL)
START MARKETING DATE: 2004-12-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68782-001_48b1952b-3ef6-4437-8592-5f4f4543e370
PRODUCT NDC: 68782-001
APPLICATION NUMBER: NDA021756

Other PEGAPTANIB SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedMacugen